JeNu Biosciences Closes $3M Funding

JeNu Biosciences, a Seattle-based technology driven beauty company, has closed a $3m funding round with Second Avenue Partners.

The company intends to use the funds to continue to grow and commercialize its JeNu Home System, a proprietary ultrasound skincare system.

JeNu Biosciences, which uses low-powered ultrasound to deliver proprietary anti-aging ingredients, was founded in 2008 by a team of industry experts, including CEO Wayne Wager, a former venture capitalist and CEO of Confirma Inc., and Colette Courtion, founder and CEO of Calidora Skin Clinics.



Join the discussion